Projects per year
Personal profile
Education
- 2005 Ph.D. (Pharmaceutics), School of Pharmacy, The Ohio State University, USA
- 1998 M.S., (Pharmacy) National Taiwan University
- 1996 B.S., School of Pharmacy, National Taiwan University
Experience
- 2016- 臺北醫學大學藥物科學學科副教授
- 2013- 臺北醫學大學中草藥臨床藥物研發博士學位學程
- 2012-2016 臺北醫學大學藥物科學學科助理教授
- 2006-2012 臺北醫學大學藥學系助理教授
Research Interests
- Delivery of gene/siRNA/antisense agents by nanoparticles or liposomes
- Targeted drug/gene/antisense delivery systems
- Nanoparticle design and synthesis
- Development of novel biomaterials for drug/gene/antisense delivery
Fingerprint
Dive into the research topics where Shih-Jiuan Chiu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Development of Multifunctionalized Nanoparticles for Delivery of Chemotherapeutic Agents to Triple-Negative Breast Cancer
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Multifunctional Nanoparticles for Cancer Therapy
8/1/15 → 7/31/16
Project: A - Government Institution › b - Ministry of Science and Technology
-
Simultaneous Delivery of an Antisense Oligonucleotide and a Chemotherapeutic Agent by a Her2-Targeted Liposomal System
8/1/12 → 7/31/13
Project: A - Government Institution › b - Ministry of Science and Technology
-
Simultaneous Delivery of an Antisense Oligonucleotide and a Chemotherapeutic Agent by a Her2-Targeted Liposomal System
8/1/11 → 7/31/12
Project: A - Government Institution › b - Ministry of Science and Technology
Research output
-
A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells
Chiu, C. F., Chiu, S. J., Bai, L. Y., Feng, C. H., Hu, J. L., Lin, W. Y., Huang, H. Y. & Weng, J. R., 2021, (Accepted/In press) In: Environmental Toxicology.Research output: Contribution to journal › Article › peer-review
-
Author Correction: FTY720 Induces Autophagy-Associated Apoptosis in Human Oral Squamous Carcinoma Cells, in Part, through a Reactive Oxygen Species/Mcl-1-Dependent Mechanism (Scientific Reports, (2017), 7, 1, (5600), 10.1038/s41598-017-06047-9)
Bai, L. Y., Chiu, C. F., Chiu, S. J., Chu, P. C. & Weng, J. R., Dec 1 2020, In: Scientific Reports. 10, 1, 3322.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
NDAT Targets PI3K-Mediated PD-L1 Upregulation to Reduce Proliferation in Gefitinib-Resistant Colorectal Cancer
Huang, T. Y., Chang, T. C., Chin, Y. T., Pan, Y. S., Chang, W. J., Liu, F. C., Hastuti, E. D., Chiu, S. J., Wang, S. H., Changou, C. A., Li, Z. L., Chen, Y. R., Chu, H. R., Shih, Y. J., Cheng, R. H., Wu, A., Lin, H. Y., Wang, K., Whang-Peng, J., Mousa, S. A. & 1 others, , Aug 3 2020, In: Cells. 9, 8Research output: Contribution to journal › Article › peer-review
Open Access3 Citations (Scopus) -
Divaricoside Exerts Antitumor Effects, in Part, by Modulating Mcl-1 in Human Oral Squamous Cell Carcinoma Cells
Weng, J. R., Bai, L. Y., Chiu, S. J., Chiu, C. F., Lin, W. Y., Hu, J. L. & Shieh, T. M., Jan 1 2019, In: Computational and Structural Biotechnology Journal. 17, p. 151-159 9 p.Research output: Contribution to journal › Article › peer-review
5 Citations (Scopus) -
A 5′ AMP-Activated Protein Kinase Enzyme Activator, Compound 59, Induces Autophagy and Apoptosis in Human Oral Squamous Cell Carcinoma
Weng, J. R., Dokla, E. M. E., Bai, L. Y., Chen, C. S., Chiu, S. J. & Shieh, T. M., Jul 2018, In: Basic and Clinical Pharmacology and Toxicology. 123, 1, p. 21-29 9 p.Research output: Contribution to journal › Article › peer-review
4 Citations (Scopus)